1. Home
  2. RANI vs CULP Comparison

RANI vs CULP Comparison

Compare RANI & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • CULP
  • Stock Information
  • Founded
  • RANI 2012
  • CULP 1972
  • Country
  • RANI United States
  • CULP United States
  • Employees
  • RANI N/A
  • CULP N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • CULP Textiles
  • Sector
  • RANI Health Care
  • CULP Consumer Discretionary
  • Exchange
  • RANI Nasdaq
  • CULP Nasdaq
  • Market Cap
  • RANI 73.8M
  • CULP 62.9M
  • IPO Year
  • RANI 2021
  • CULP N/A
  • Fundamental
  • Price
  • RANI $1.44
  • CULP $5.48
  • Analyst Decision
  • RANI Strong Buy
  • CULP
  • Analyst Count
  • RANI 5
  • CULP 0
  • Target Price
  • RANI $11.80
  • CULP N/A
  • AVG Volume (30 Days)
  • RANI 505.2K
  • CULP 19.8K
  • Earning Date
  • RANI 11-14-2024
  • CULP 12-04-2024
  • Dividend Yield
  • RANI N/A
  • CULP N/A
  • EPS Growth
  • RANI N/A
  • CULP N/A
  • EPS
  • RANI N/A
  • CULP N/A
  • Revenue
  • RANI N/A
  • CULP $222,157,000.00
  • Revenue This Year
  • RANI N/A
  • CULP $1.94
  • Revenue Next Year
  • RANI N/A
  • CULP $10.13
  • P/E Ratio
  • RANI N/A
  • CULP N/A
  • Revenue Growth
  • RANI N/A
  • CULP N/A
  • 52 Week Low
  • RANI $1.44
  • CULP $4.25
  • 52 Week High
  • RANI $8.75
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • RANI 25.81
  • CULP 56.29
  • Support Level
  • RANI $1.90
  • CULP $5.29
  • Resistance Level
  • RANI $2.00
  • CULP $5.11
  • Average True Range (ATR)
  • RANI 0.11
  • CULP 0.25
  • MACD
  • RANI -0.04
  • CULP 0.06
  • Stochastic Oscillator
  • RANI 12.70
  • CULP 72.35

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: